Euvegal® forte

Euvegal® forte informations

Schwabe

.

 

Euvegal® - WS® 1014, WS® 1303

for restlessness and sleep-induction disturbances due to nervous conditions

Active ingredient:

Dry extract from Valerian root WS® 1014 and dry extract from Melissa leaves WS® 1303
Approximately 20 – 30 % of the patients consulting a general practitioner report on nervous unrest and sleep disturbances such as insomnia. Common triggers of these conditions include everyday issues such as school- or job pressure, family or marital problems. The use of synthetic tranquillizers and sedatives is widespread, but may include the risk of significant side effects.
Euvegal® contains the standardised dry extracts WS® 1014 from valerian root and WS® 1303 from melissa leaves and is a clinically proven treatment for restlessness and sleep disturbances. It improves sleep quality and well-being during the day and has an excellent tolerability without the risk of hang-overs or addiction. Euvegal® has no negative influence on concentration and mental performance.

Approved indication in Germany:

Restlessness; sleep-induction disturbances due to nervous conditions


Note: If conditions persist, are unclear or new, consult a doctor as diseases requiring medical clarification might be involved.

For information on precautions for use, side effects and contra-indications see the package leaflet or contact your doctor or pharmacist.

Data based on information issued 2008/05
Euvegal®

Euvegal®

Path Navigation

Main Navigation



Latest News

  • Ginkgo biloba extract is effective for cognitive decline

    Read more

Service Navigation

Help

You can change the Font Size here:

Font Size

Contactinformation

Dr. Willmar Schwabe Pharmaceuticals
Willmar-Schwabe-Straße 4
76227 Karlsruhe, Germany

Phone +49 (0) 7 21-40 05-1 01
Fax +49 (0) 7 21-40 05-2 02

www.schwabepharma.com